US Patent

US9820960 — Fumarate ester pharmaceutical compositions

Formulation · Assigned to Banner Life Sciences LLC · Expires 2035-02-27 · 9y remaining

Vulnerability score 30/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions, specifically oral formulations, containing fumarate esters, such as monomethyl fumarate.

USPTO Abstract

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.

Drugs covered by this patent

monomethyl-fumarate (MONOMETHYL FUMARATE)

Patent Metadata

Patent number: US9820960
Jurisdiction: US
Classification: Formulation
Expires: 2035-02-27
Drug substance claim: No
Drug product claim: Yes
Assignee: Banner Life Sciences LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.